Article info
Hepatology
Original article
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
- Correspondence to Dr Sophie Lotersztajn, Centre de Recherche sur l’Inflammation, INSERM UMR 1149- Université Paris Diderot, Faculté de Médecine Xavier Bichat, Paris 75018, France; sophie.lotersztajn{at}inserm.fr
Citation
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
Publication history
- Received January 31, 2018
- Revised August 8, 2018
- Accepted September 2, 2018
- First published October 9, 2018.
Online issue publication
March 19, 2019
Article Versions
- You are viewing the most recent version of this article.
- Previous version (19 March 2019).
- latest version (19 March 2019).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.